| |
Interpreting
and understanding the requirements of Regulation 429/2008 and Regulation
1831/2003 is challenging and time consuming. Whether you are
interested in chemically-defined feed additives, micro-organisms
or enzymes, with Cyton on your team you can be confident of clear
understanding and proven interpretation of the Regulations and
Directives, meaning your product is more likely to meet with marketing
approval more quickly.
Section II
- Pharmaceutical and analytical development: strategic advice
and support
- Planning and managing development projects
- All aspects of Section II of the dossier
- Scientific Summary
Section III
- Pharmacological, toxicological and residues development:
strategic advice and support
- Management of pharmacological, toxicological, residues and
ecotoxicological studies
- Preparation of Section IV of the dossier
- Scientific Summary
Section
IV
- Pre-Clinical and Clinical development: strategic advice
and support
- Management of Pre-Clinical and Clinical studies
- Experience with all target species, including fish
- Preparation of Section III of the dossier
- Scientific Summary
|
|
| |
|
|
